This HTML5 document contains 151 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n8http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43582605
rdf:type
wikibase:Item
schema:description
tudományos cikk 2009年の論文 article científic мақолаи илмӣ artigo científico 2009年学术文章 2009年學術文章 2009年學術文章 vetenskaplig artikel vitskapeleg artikkel 2009年學術文章 wissenschaftlicher Artikel מאמר מדעי artigo científico artykuł naukowy научни чланак scientific article published on 17 May 2009 ১৭ মে ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ bài báo khoa học artículo científico publicado en 2009 articolo scientifico artikull shkencor 2009年学术文章 บทความทางวิทยาศาสตร์ artigo científico naučni članak vedecký článok научна статия 2009年学术文章 مقالة علمية نشرت في 17 مايو 2009 bilimsel makale artikel ilmiah 2009년 논문 article scientifique scientific article published on 17 May 2009 artikulong pang-agham 2009年學術文章 2009年学术文章 teaduslik artikkel videnskabelig artikel სამეცნიერო სტატია 2009 nî lūn-bûn 2009年學術文章 επιστημονικό άρθρο scienca artikolo наукова стаття, опублікована в травні 2009 artículu científicu espublizáu en 2009 vitenskapelig artikkel научная статья wetenschappelijk artikel tieteellinen artikkeli vědecký článek 2009年学术文章 articol științific 2009年学术文章 научни чланак article scientific scientific article published on 17 May 2009
p:P577
wds:Q43582605-87C28934-6D4D-4F04-92C0-3BBFFEA6F487
wdt:P577
2009-05-17T00:00:00Z
p:P407
wds:Q43582605-BBA5DD7F-7C77-4EBC-BE8B-E92C5841F9DD
wdt:P407
wd:Q1860
p:P2860
wds:Q43582605-3C32FC31-7BC5-4BF3-A4FD-08D48A8EAECF wds:Q43582605-4FA82876-F401-4387-A6B8-D6A5D8D298E8 wds:Q43582605-540A3E41-9F28-4383-984B-73EEFE3E7D12 wds:Q43582605-5DC34CF2-750E-4C6E-8F91-F276485CC346 wds:Q43582605-73BF9028-E60A-49BE-9D6E-4FBDFBDBF4EF wds:Q43582605-787B1066-B71F-40C4-8FA8-55544036B843 wds:Q43582605-8527B478-9D5D-477E-9325-5079B7DC8344 wds:Q43582605-8D0DC33A-DAEF-465C-8337-988DA9479E84 wds:Q43582605-944A5557-BAFE-46E3-9ECC-BF652376D46A wds:Q43582605-9EE50BB2-22CE-4A27-916A-A66F48DD0A2B wds:Q43582605-A9755FE8-F4F7-4018-BD82-21669A32256A wds:Q43582605-C1A49E35-3D98-4AA6-B6B0-349A899F6F87 wds:Q43582605-C828CE67-BDE1-4D55-A86A-67A65B8461EC wds:Q43582605-CF4BCFA5-2A58-4795-8C99-FE183409AA5D wds:Q43582605-D526F99F-189C-48C0-BBFA-0F86ECDE0828 wds:Q43582605-D577DEAD-4006-42ED-A10C-D0E10618D741 wds:Q43582605-E3B02DB6-C1CE-4D3C-A014-E0A24745F01D wds:Q43582605-ECF7EC15-5CAE-49BB-AB3D-D6376F6E6BF8 wds:Q43582605-083E92E0-0464-4517-943B-BCE6BE645FD0 wds:Q43582605-1607B3DD-3B21-403A-B23F-01BC20E1DF6A wds:Q43582605-1B236949-E2E6-4B49-8259-7B5061685ADB wds:Q43582605-2063D1E9-F3CC-4D01-8FD3-7F0B68CC0824 wds:Q43582605-23907150-10E1-4077-A451-D8184CFFDEC2 wds:Q43582605-2EB0E098-7854-4E51-877C-9B34C2D78786
wdt:P2860
wd:Q35979245 wd:Q73293449 wd:Q31440187 wd:Q45072359 wd:Q53995002 wd:Q40708166 wd:Q33369422 wd:Q30442291 wd:Q35756716 wd:Q79572077 wd:Q40894645 wd:Q28335131 wd:Q28370802 wd:Q80356257 wd:Q46957880 wd:Q45008992 wd:Q34699440 wd:Q45994601 wd:Q35752061 wd:Q43675453 wd:Q45976411 wd:Q29547293 wd:Q36644450 wd:Q54039002
p:P2093
wds:Q43582605-3B0EA581-748A-46F0-94E3-3559075BDCB6 wds:Q43582605-2F28B2E9-3CDA-4836-B59B-A5D28C7BAFE5 wds:Q43582605-7492EE99-2B20-448D-9252-06FF67AA157D wds:Q43582605-6510A412-FE2A-49E9-8717-49821EB6A47A wds:Q43582605-427DE3CE-B145-4A06-A4F3-187DE4908282
wdt:P2093
Lafit Ramos Judith K Wolf Janos L Tanyi Crystal L Parker Judith A Smith
rdfs:label
Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer
skos:prefLabel
Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer
schema:name
Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer
p:P50
wds:Q43582605-9ADBF4A1-5B56-471E-9C3A-9C5BF8BB0A77
wdt:P50
wd:Q90326364
p:P1476
wds:Q43582605-C04DDB2A-E72A-4FF3-B3E9-E201AFD8CDDD
wdt:P1476
Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer
p:P304
wds:Q43582605-8C42303C-142D-4FE6-90C2-F00415560608
wdt:P304
219-224
p:P31
wds:Q43582605-BD57A625-8802-4A9C-B15D-25B94D6AF835
wdt:P31
wd:Q13442814
p:P921
wds:Q43582605-258621CF-BF7D-4649-AA0E-AC88CC75FC09 wds:Q43582605-7E70A047-0B78-44A4-AA4C-C064549EB9A4
wdt:P921
wd:Q18936 wd:Q172341
p:P698
wds:Q43582605-BD155CCB-256F-4D3D-BEA2-0497049A5FB7
wdtn:P698
n12:19446868
wdt:P698
19446868
p:P1433
wds:Q43582605-3576686F-8106-4E86-A666-310BD02533A9
wdt:P1433
wd:Q5625182
p:P433
wds:Q43582605-2236D070-7DEA-4DA0-96B6-1C12ED1F8657
p:P478
wds:Q43582605-EE85B436-A56F-444C-B766-A67DA30F4313
wdt:P433
2
wdt:P478
114
p:P356
wds:Q43582605-E1F54568-C7C1-4EA4-8DF5-7381C2E65F49
wdtn:P356
n8:J.YGYNO.2009.04.007
wdt:P356
10.1016/J.YGYNO.2009.04.007